Target intelligence / Profile preview

Novel transcript, sense overlapping RP11-90L9.1 (ENSG00000296787)

Target: ENSG00000296787
Molecular classification: Long noncoding RNA, Noncoding transcript

Overview

ENSG00000296787 (novel transcript, sense overlapping RP11-90L9.1) is a gene annotated as a long noncoding RNA (lncRNA) in current genomic databases[1]. It is classified as a non-protein coding transcript and does not encode a recognized receptor, transporter, channel, enzyme, or other protein of therapeutic interest. There is no evidence in the scientific literature or curated biomedical resources supporting its role as a direct therapeutic target or in disease mechanisms. No molecular function, clinical implication, or pharmacological relevance has been established for this RNA at present[1]. It remains a locus of unknown function, typically identified in large-scale transcriptomic surveys.

Other names: RP11-90L9.1

Biological functions

Unknown (No experimentally validated functions are defined in major databases[1]; given analogy to other annotated lncRNAs, possible regulatory roles in gene expression may be hypothesized)

Disease associations

Other (No reported involvement in specific diseases or disease pathways; not reported in cancer, inflammation, or other major categories[1])

Beyond the preview

Go deeper on Novel transcript, sense overlapping RP11-90L9.1 (ENSG00000296787).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense overlapping RP11-90L9.1 (ENSG00000296787).

Explore the full profile